OCULAR THERAPEUTIX, INC·4

Oct 14, 9:04 PM ET

White Christopher G 4

4 · OCULAR THERAPEUTIX, INC · Filed Oct 14, 2022

Insider Transaction Report

Form 4
Period: 2022-10-13
White Christopher G
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-10-13+7,0007,000 total
    Exercise: $4.19Exp: 2032-10-12Common Stock (7,000 underlying)
Footnotes (1)
  • [F1]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Documents

1 file
  • 4
    tm2228232-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT